Relay Therapeutics, Inc. Public Float
Relay Therapeutics, Inc. (RLAY) had Public Float of $585.50 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $585.50M.
- 2024-06-30: Entity Public Float $859.30M.
- 2023-06-30: Entity Public Float $1.50B.
- 2022-06-30: Entity Public Float $1.80B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $585.50M 10-K · filed 2026-02-26 |
| 2024-06-30 | $859.30M 10-K · filed 2025-02-26 |
| 2023-06-30 | $1.50B 10-K · filed 2024-02-22 |
| 2022-06-30 | $1.80B 10-K · filed 2023-02-23 |
| 2021-06-30 | $2.26B 10-K · filed 2022-02-24 |
| 2020-07-20 | $2.54B 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |